Originally published in 1981, this comprehensive volume is intended for medical economists, clinical pharmacologists, physicians, pharmacists and consumers, as well as planner and administrators who must determine relevant policy and legislation in the area of the provision of medicines. The contributors believe that the system of drugs provision can benefit from being studied, by policy revisions and evaluation of the outcomes of policy operations.
Originally published in 1981, this comprehensive volume is intended for medical economists, clinical pharmacologists, physicians, pharmacists and consumers, as well as planner and administrators who must determine relevant policy and legislation in the area of the provision of medicines.
Arvustused
'The book is a positive contribution to the literature...It is amply documented through a bountiful list of references and additional readings of truly international scope.' Albert I. Wertheimer, College of Pharmacy, University of Minnesota, USA.
1. Medicines The Interested Parties
2. The Use of Medicines for
Illness
3. The Introduction of New Drugs
4. The Promotion of Prescription
Drugs and Other Puzzles
5. Information and Education About Drugs
6. Factors
Affecting Individual Use of Medicines
7. Economic Considerations in the
Provision and Use of Medicines8. The Role of International Organisations in
Medicines Policy
9. Coherent Policies on Drugs: Formulation and Implementation
Richard Blum was Chairman of the International Research Group for Drug Legislation and Programs. Andrew Herxheimer was a consultant at the Charing Cross Hospital in London and Professor of Pharmacology at the University of Groningen, The Netherlands. Catherine Stenzl was Coordinator of the International Research Group for Drug Legislation and Programs. Jasper Woodcock was Director of the Institute for the Study of Drug Dependence London.
Lisainfo e-raamatute kohta